CY1107858T1 - Ccr5 αντισωματα pa14 - Google Patents

Ccr5 αντισωματα pa14

Info

Publication number
CY1107858T1
CY1107858T1 CY20081100062T CY081100062T CY1107858T1 CY 1107858 T1 CY1107858 T1 CY 1107858T1 CY 20081100062 T CY20081100062 T CY 20081100062T CY 081100062 T CY081100062 T CY 081100062T CY 1107858 T1 CY1107858 T1 CY 1107858T1
Authority
CY
Cyprus
Prior art keywords
monoclonal antibody
ccr5
binds
fragment
options
Prior art date
Application number
CY20081100062T
Other languages
Greek (el)
English (en)
Inventor
William C Olson
Paul J Maddon
Original Assignee
Progenics Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharmaceuticals, Inc. filed Critical Progenics Pharmaceuticals, Inc.
Publication of CY1107858T1 publication Critical patent/CY1107858T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CY20081100062T 1998-12-16 2008-01-17 Ccr5 αντισωματα pa14 CY1107858T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21279398A 1998-12-16 1998-12-16
US11253298P 1998-12-16 1998-12-16
EP99966466A EP1144006B1 (en) 1998-12-16 1999-12-16 CCR5 Antibody PA14

Publications (1)

Publication Number Publication Date
CY1107858T1 true CY1107858T1 (el) 2013-06-19

Family

ID=26810060

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100062T CY1107858T1 (el) 1998-12-16 2008-01-17 Ccr5 αντισωματα pa14

Country Status (13)

Country Link
EP (2) EP1144006B1 (https=)
JP (1) JP2002538771A (https=)
AT (1) ATE375802T1 (https=)
AU (3) AU773175B2 (https=)
CA (1) CA2355607A1 (https=)
CY (1) CY1107858T1 (https=)
DE (1) DE69937369T2 (https=)
DK (1) DK1144006T3 (https=)
ES (1) ES2296416T3 (https=)
HK (1) HK1041207B (https=)
MX (1) MXPA01006097A (https=)
PT (1) PT1144006E (https=)
WO (1) WO2000035409A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0847452B1 (en) 1995-06-07 2009-04-01 Progenics Pharmaceuticals, Inc. Monoclonal antibody for inhibiting hiv-1 envelope glycoprotein mediated membrane fusion
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU2265701A (en) * 1999-12-16 2001-06-25 Tanox, Inc. Anti-hiv-1 conjugates for treatment of hiv disease
US7138119B2 (en) 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7060273B2 (en) 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20020146415A1 (en) * 2001-04-06 2002-10-10 Olson William C. Methods for inhibiting HIV-1 infection
US20060078537A1 (en) * 2001-12-21 2006-04-13 Matthias Mack Mono-and dual chemokine/cytokine constructs
DE60324664D1 (de) * 2002-02-22 2008-12-24 Pdl Biopharma Inc Anti-ccr5 antikörper
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
TW200720289A (en) 2005-04-01 2007-06-01 Hoffmann La Roche Antibodies against CCR5 and uses thereof
JP2009525301A (ja) * 2006-01-30 2009-07-09 エフ．ホフマン−ラ ロシュ アーゲー Ｈｉｖを処置するための相乗的組成物
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
AU2007286451A1 (en) 2006-08-17 2008-02-21 F. Hoffmann-La Roche Ag A conjugate of an antibody against CCR5 and an antifusogenic peptide
KR20090052358A (ko) 2006-09-29 2009-05-25 에프. 호프만-라 로슈 아게 Ｃｃｒ5 에 대한 항체 및 이의 용도
CL2008000707A1 (es) 2007-03-13 2008-09-22 Hoffmann La Roche Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.
EP2741777B1 (en) 2011-08-12 2017-01-18 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3375697A (en) * 1996-05-28 1998-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cc chemokine receptor 5, antibodies thereto, transgenic animals
AU735460B2 (en) * 1996-06-14 2001-07-12 Aaron Diamond Aids Research Center, The Uses of a chemokine receptor for inhibiting HIV-1 infection
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
AU2004205165A1 (en) 2004-09-16
EP2088158A2 (en) 2009-08-12
CA2355607A1 (en) 2000-06-22
AU2004205164A1 (en) 2004-09-16
JP2002538771A (ja) 2002-11-19
PT1144006E (pt) 2007-12-11
EP1144006A4 (en) 2004-11-24
DE69937369T2 (de) 2008-07-24
AU2199600A (en) 2000-07-03
HK1041207B (en) 2007-12-28
EP1144006A2 (en) 2001-10-17
ATE375802T1 (de) 2007-11-15
DK1144006T3 (da) 2007-11-26
DE69937369D1 (de) 2007-11-29
HK1041207A1 (en) 2002-07-05
WO2000035409A3 (en) 2000-09-14
AU773175B2 (en) 2004-05-20
ES2296416T3 (es) 2008-04-16
EP1144006B1 (en) 2007-10-17
MXPA01006097A (es) 2002-04-15
WO2000035409A2 (en) 2000-06-22
EP2088158A3 (en) 2010-01-20

Similar Documents

Publication Publication Date Title
CY1107858T1 (el) Ccr5 αντισωματα pa14
NZ616992A (en) Anti-ilt7 antibody
ATE208820T1 (de) Humanisierte antikoerper
IL226637A0 (en) An isolated heterodimeric cytokine receptor
CA2221893A1 (fr) Anticorps specifique de staphylococcus aureus et utilisations
ATE324381T1 (de) Mutiertes scfv-fragment des okt-3 antikörpers
RU2005132389A (ru) Гуманизированное анти-cd4 антитело с иммунодепрессивными свойствами
DK0614374T4 (da) Monoklonalt museantistof (5c8) genkender et menneskeligt glycoprotein på overfladen af T-lymfocytter
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
NZ712762A (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
DE60014124D1 (de) Antikörper, die spezifisch für fullerene sind
ATE508193T1 (de) Menschliches rezeptor für zytokine
NZ501990A (en) Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
ES2015654A6 (es) Un procedimiento para preparar anticuerpos anti-idiotipicos para antigeno asociado con melanoma, de alto peso molecular anti-humano.
ATE58172T1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
MX9702422A (es) Anticuerpos recombinantes contra fas y adn para los mismos.
ATE229080T1 (de) Monoklonale antikörper gegen ck-mb
AU2707992A (en) Monoclonal antibodies to hepatitis c virus
SI1396501T1 (sl) Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr
BR9702101A (pt) Hibridoma e anticorpo monoclonal
DE69229573D1 (de) Monoklonaler Antikörper, Polypeptide und deren Herstellung
EP0265156A3 (en) Monoclonal antibodies
KR970701735A (ko) 프로스타글란딘 e 수용체(prostaglandin e receptor)
EP0349258A3 (en) Method of determining the differentiation of a human t-cell